Multiple tumor cell subsets associated with different EMT stages have been identified [61], reflecting heterogeneous levels of markers previously associated with tumor stemness, EMT, or metastasis initiation—such as CD61, CD51, and CD106 [80,81,82,83,84]. This evidence concerns the gene ITGB3 and neoplasm.